| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8230184 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 9 Pages |
Abstract
The risk of AUR is not associated with dose delivered to different regions of the prostate. However, a higher dose to the bladder neck and a larger extent of prostate protrusion into the bladder are risk factors for the development of AUR after I-125 prostate brachytherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ellen M.A. M.D., Evelyn M. Ph.D., Jan J. M.D. Ph.D., Joep G.H. M.D., Marinus A. Ph.D., Marco M.D., Ph.D.,